Sponsor Dossier
MedTAS
Sponsor Dossier for MedTAS. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ALIMETREX
- Brand: APO-VORICONAZOLE
- Brand: ARIMIZOLE
- Brand: CANCIGIN
- Brand: CASPODAS
- Brand: CASPOFUNGIN JUNO
- Brand: CEFTRIAXON
- Brand: CEFTRIX
- Device (sponsor): Multi-purpose saline solution
- Device (sponsor): Lubricant, eye
- Device (sponsor): Lubricant, eye
About
MedTAS is an Australian Private Company with ABN 72644270860, registered in NSW. The entity is active and registered for GST.
Portfolio
MedTAS has 53 brands on the ARTG, of which 6 are indexable and 4 carry a Product Information document. 5 brands are PBS-listed, 0 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ALIMETREX, APO-VORICONAZOLE, ARIMIZOLE, CANCIGIN, CASPODAS, CASPOFUNGIN JUNO, CEFTRIAXON, CEFTRIX, CISATRACURIUM MYLAN, CYKLOTRAN, CYKLOTRANEXAMIC, Dapsone.
Therapeutic focus
— Infectious Disease: 15 brands — Gastroenterology: 8 brands — Oncology: 6 brands — Endocrinology: 6 brands — Pain Management: 5 brands — Cardiology: 3 brands — Haematology: 3 brands — Neurology: 2 brands — Musculoskeletal: 1 brand — Immunology: 1 brand — Reproductive Health: 1 brand — Complementary Medicine: 1 brand — Psychiatry: 1 brand
PBS footprint
5 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.